SCI Pharmtech, Inc. (TPE: 4119)

SCI Pharmtech Revenue

SCI Pharmtech had revenue of 392.72M TWD in the quarter ending June 30, 2024, with 25.42% growth. This brings the company's revenue in the last twelve months to 1.25B, up 5.62% year-over-year. In the year 2023, SCI Pharmtech had annual revenue of 1.20B with 33.83% growth.

• Revenue (ttm): 1.25B
• Revenue Growth: +5.62%
• P/S Ratio: 8.34
• Revenue / Employee: 5.24M
• Employees: 239
• Market Cap: 10.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.20B	304.42M	33.83%
Dec 31, 2022	899.74M	35.52M	4.11%
Dec 31, 2021	864.22M	-1.83B	-67.86%
Dec 31, 2020	2.69B	333.48M	14.16%
Dec 31, 2019	2.36B	415.83M	21.44%